Author: Jon Sabes

Dr. Morgan Levine: You have two ages. It matters

I have the pleasure of working with Dr. Morgan Levine, one of the world’s leading researchers in biological aging.  And now thanks to a report from  CNN you can have insights into her work.  WATCH CNN VIDEO HERE. Dr. Levine published a seminal research paper in 2018 entitled “An epigenetic biomarker of aging for lifespan and health span.”  This work builds from the research published by Dr. Steve Horvath on predictive human longevity.  Dr. Levine takes that research to another level looking more precisely at biomarkers which indicate risk of early mortality. According to Levine’s research, essentially, everyone has two...

Read More

Epigenetic and Insurtech Update, Week of November 12, 2018

Epigenetic and Insurtech Update, Week of November 12, 2018 Jon Sabes on the SpotOn Insurance Podcast: The Science of Epigenetics and Life Insurance The new frontiers of epigenetics–the-new-frontiers-of-epigenetics-65076 Methylation-based cancer early detection shows promise in preliminary trials DNA methylation changes uncovered in undernourished children The Internet of Bodies is Here. Are Courts and Regulators Ready? Detecting Cancer Earlier from Blood Tests Made Possible by AI The Amazing Ways AI is Transforming Genomics and Gene Editing Offering Free DNA Sequencing, Nebula Genomics is Open for Business. But There’s an Itsy-Bitsy Catch Evolution...

Read More

DNA Methylation: Timekeeper of Biological Age

This recorded webinar on biological aging was published on June 1, 2018 and given by Dr. Steve Horvath.  Cellular senescence, telomere shortening, and changes in gene expression have been well documented to contribute to the aging process. Recently, researchers have found that epigenetic changes, such as the presence of methyl groups in close proximity to CpG dinucleotides located near a gene’s promoter, correlate with age. Technological advances, including microarray analysis and next-generation sequencing, have clarified the relationship between DNA methylation and aging, to the point that such phenomena may even be used to predict one’s chronological age. For a...

Read More

Epigenetic and Insurtech Update, Week of November 5, 2018

Epigenetic and Insurtech Update, Week of November 5, 2018 The key to a long life has little to do with ‘good genes’  WIRED How Dad’s Stresses Get Passed Along to Offspring – Scientific American Jon Sabes on Bloomberg Radio: YouSurance Uses Epigenetics to Predict Life Expectancy The Key to a Long Life Has Little to Do with ‘Good Genes’ Being Fit May Be as Good for You as Not Smoking DNA evidence could soon tell cops your age, whether you smoke, and what you ate for breakfast Gene signature discovery may predict response to...

Read More

Epigenetic and Insurtech Update, Week of October 29, 2018

Ring-Shaped Protein Complex Wrangles DNA DNA sequencing giant Illumina just bought rival Pac Bio for $1.2 billion — here’s why   Reset Your DNA to Slow the Clock   Studies raise questions over how epigenetic information is inherited   20 Minutes With: Color Genomics CEO Othman Laraki   Regulators just gave DNA-testing startup 23andMe the go-ahead to offer a health product that scientists have called dubious   23andMe’s genetic test for how you’ll react to medication is ahead of its time   Insurtech unicorns drive insurance tech funding in Q3: CB Insights...

Read More

Follow me on Twitter

Follow Jon Sabes


Jon Sabes

Jon Sabes

Creativity is only limited by our imagination and willingness to work towards its realization - resident artist in business. I serve as the Chief Executive Officer of Nasdaq: GWGH

View Full Profile →

Subscribe to My Blog via Email

Enter your email address.

Listen to Podcasts

%d bloggers like this: